What Changed at Proscia

Every material change AI Health Index has tracked at Proscia: new modules, model and architecture updates, clinical evidence, regulatory status, security certifications, and integration depth. Each entry states what changed, cites its source, and carries our read on what it means for a buyer. The graded assessment of this vendor across all fifteen capability axes sits on its index profile.

Funding rounds, valuations, and awards are not product changes and are not logged here. Acquisitions appear only where there is direct product impact.

Impact

Type

1 entry

Showing changes for Proscia only.Show the full log

August 2026

P

Proscia

Aug 6, 2026

HighVerified

Regulatory / FDA

Proscia received a new FDA 510(k) clearance for its Concentriq AP-Dx digital pathology platform. The clearance introduces a Predetermined Change Control Plan (PCCP), adds cloud deployment capabilities, and expands interoperability to include the Leica Aperio GT 450 DX slide scanner.

Our read

The inclusion of a PCCP allows laboratories to adopt future FDA-cleared scanners and displays without waiting for Proscia to submit additional 510(k) filings. The newly cleared cloud deployment option and expanded scanner compatibility also provide health systems with flexibility in how they implement and scale their digital pathology infrastructure.

Related axis: FDA and Regulatory StatusVendor announcementView source